» Articles » PMID: 23946404

A Dramatic Increase of C1q Protein in the CNS During Normal Aging

Abstract

The decline of cognitive function has emerged as one of the greatest health threats of old age. Age-related cognitive decline is caused by an impacted neuronal circuitry, yet the molecular mechanisms responsible are unknown. C1q, the initiating protein of the classical complement cascade and powerful effector of the peripheral immune response, mediates synapse elimination in the developing CNS. Here we show that C1q protein levels dramatically increase in the normal aging mouse and human brain, by as much as 300-fold. This increase was predominantly localized in close proximity to synapses and occurred earliest and most dramatically in certain regions of the brain, including some but not all regions known to be selectively vulnerable in neurodegenerative diseases, i.e., the hippocampus, substantia nigra, and piriform cortex. C1q-deficient mice exhibited enhanced synaptic plasticity in the adult and reorganization of the circuitry in the aging hippocampal dentate gyrus. Moreover, aged C1q-deficient mice exhibited significantly less cognitive and memory decline in certain hippocampus-dependent behavior tests compared with their wild-type littermates. Unlike in the developing CNS, the complement cascade effector C3 was only present at very low levels in the adult and aging brain. In addition, the aging-dependent effect of C1q on the hippocampal circuitry was independent of C3 and unaccompanied by detectable synapse loss, providing evidence for a novel, complement- and synapse elimination-independent role for C1q in CNS aging.

Citing Articles

Neuroinflammation in Alzheimer disease.

Heneka M, van der Flier W, Jessen F, Hoozemanns J, Thal D, Boche D Nat Rev Immunol. 2024; .

PMID: 39653749 DOI: 10.1038/s41577-024-01104-7.


Loss of C1q alters the auditory brainstem response.

Chokr S, Bui-Tran A, Cramer K Front Cell Neurosci. 2024; 18:1464670.

PMID: 39416682 PMC: 11480778. DOI: 10.3389/fncel.2024.1464670.


Dysregulated C1q and CD47 in the aging monkey brain: association with myelin damage, microglia reactivity, and cognitive decline.

DeVries S, Dimovasili C, Medalla M, Moore T, Rosene D Front Immunol. 2024; 15:1426975.

PMID: 39399501 PMC: 11466761. DOI: 10.3389/fimmu.2024.1426975.


A microglial compliment: controlling neuronal function from within.

Hasavci D, Blank T Signal Transduct Target Ther. 2024; 9(1):267.

PMID: 39370427 PMC: 11456583. DOI: 10.1038/s41392-024-01989-9.


Aging Microglia and Their Impact in the Nervous System.

von Bernhardi R, Eugenin J Adv Neurobiol. 2024; 37:379-395.

PMID: 39207703 DOI: 10.1007/978-3-031-55529-9_21.


References
1.
Bolliger M, Martinelli D, Sudhof T . The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins. Proc Natl Acad Sci U S A. 2011; 108(6):2534-9. PMC: 3038708. DOI: 10.1073/pnas.1019577108. View

2.
Boulanger L . Immune proteins in brain development and synaptic plasticity. Neuron. 2009; 64(1):93-109. DOI: 10.1016/j.neuron.2009.09.001. View

3.
Burke S, Barnes C . Neural plasticity in the ageing brain. Nat Rev Neurosci. 2005; 7(1):30-40. DOI: 10.1038/nrn1809. View

4.
Uemura T, Lee S, Yasumura M, Takeuchi T, Yoshida T, Ra M . Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell. 2010; 141(6):1068-79. DOI: 10.1016/j.cell.2010.04.035. View

5.
Drew W, Miller L, Baugh E . Effects of delta9-THC, LSD-25 and scopolamine on continuous, spontaneous alternation in the Y-maze. Psychopharmacologia. 1973; 32(2):171-82. DOI: 10.1007/BF00428688. View